149 related articles for article (PubMed ID: 33128233)
1. A survey of the young person's experience of Graves' disease and its management.
Lane LC; Rankin J; Cheetham T
Clin Endocrinol (Oxf); 2021 Feb; 94(2):330-340. PubMed ID: 33128233
[TBL] [Abstract][Full Text] [Related]
2. Impaired Quality of Life After Radioiodine Therapy Compared to Antithyroid Drugs or Surgical Treatment for Graves' Hyperthyroidism: A Long-Term Follow-Up with the Thyroid-Related Patient-Reported Outcome Questionnaire and 36-Item Short Form Health Status Survey.
Törring O; Watt T; Sjölin G; Byström K; Abraham-Nordling M; Calissendorff J; Cramon PK; Filipsson Nyström H; Hallengren B; Holmberg M; Khamisi S; Lantz M; Wallin G
Thyroid; 2019 Mar; 29(3):322-331. PubMed ID: 30667296
[TBL] [Abstract][Full Text] [Related]
3. The Long-Term Outcome of Treatment for Graves' Hyperthyroidism.
Sjölin G; Holmberg M; Törring O; Byström K; Khamisi S; de Laval D; Abraham-Nordling M; Calissendorff J; Lantz M; Hallengren B; Filipsson Nyström H; Wallin G
Thyroid; 2019 Nov; 29(11):1545-1557. PubMed ID: 31482765
[No Abstract] [Full Text] [Related]
4. Quality-of-Life Impairments Persist Six Months After Treatment of Graves' Hyperthyroidism and Toxic Nodular Goiter: A Prospective Cohort Study.
Cramon P; Winther KH; Watt T; Bonnema SJ; Bjorner JB; Ekholm O; Groenvold M; Hegedüs L; Feldt-Rasmussen U; Rasmussen ÅK
Thyroid; 2016 Aug; 26(8):1010-8. PubMed ID: 27370744
[TBL] [Abstract][Full Text] [Related]
5. Variation in the use of definitive treatment options in the management of Graves' disease: a UK clinician survey.
Hookham J; Collins EE; Allahabadia A; Balasubramanian SP
Postgrad Med J; 2017 Apr; 93(1098):198-204. PubMed ID: 27531964
[TBL] [Abstract][Full Text] [Related]
6. Treatment choice, satisfaction and quality of life in patients with Graves' disease.
Conaglen HM; Tamatea JAU; Conaglen JV; Elston MS
Clin Endocrinol (Oxf); 2018 Jun; 88(6):977-984. PubMed ID: 29633307
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology, management and outcomes of Graves' disease-real life data.
Hussain YS; Hookham JC; Allahabadia A; Balasubramanian SP
Endocrine; 2017 Jun; 56(3):568-578. PubMed ID: 28478488
[TBL] [Abstract][Full Text] [Related]
8. Selenium supplementation for patients with Graves' hyperthyroidism (the GRASS trial): study protocol for a randomized controlled trial.
Watt T; Cramon P; Bjorner JB; Bonnema SJ; Feldt-Rasmussen U; Gluud C; Gram J; Hansen JL; Hegedüs L; Knudsen N; Bach-Mortensen P; Nolsøe R; Nygaard B; Pociot F; Skoog M; Winkel P; Rasmussen AK
Trials; 2013 Apr; 14():119. PubMed ID: 23782950
[TBL] [Abstract][Full Text] [Related]
9. [Radioiodine versus surgery in the treatment of Graves' hyperthyroidism].
Jukić T; Stanicić J; Petric V; Kusić Z
Lijec Vjesn; 2010; 132(11-12):355-60. PubMed ID: 21294325
[TBL] [Abstract][Full Text] [Related]
10. Graves' disease in children and adolescents: response to long-term treatment.
Barrio R; López-Capapé M; Martinez-Badás I; Carrillo A; Moreno JC; Alonso M
Acta Paediatr; 2005 Nov; 94(11):1583-9. PubMed ID: 16303698
[TBL] [Abstract][Full Text] [Related]
11. Management of Graves' disease in Australia.
Walsh JP
Aust N Z J Med; 2000 Oct; 30(5):559-66. PubMed ID: 11108065
[TBL] [Abstract][Full Text] [Related]
12. Graves' disease: a long-term quality-of-life follow up of patients randomized to treatment with antithyroid drugs, radioiodine, or surgery.
Abraham-Nordling M; Törring O; Hamberger B; Lundell G; Tallstedt L; Calissendorff J; Wallin G
Thyroid; 2005 Nov; 15(11):1279-86. PubMed ID: 16356093
[TBL] [Abstract][Full Text] [Related]
13. Quality of life and decision regret in patients with late-hypothyroidism after radioiodine treatment for Graves' disease.
Li Y; Yang T; Ju L; Feng Y; Chen Z; Xiang X; Zhu T; Pang H; Wang Z
Clin Endocrinol (Oxf); 2024 Jan; 100(1):87-95. PubMed ID: 37964632
[TBL] [Abstract][Full Text] [Related]
14. Childhood Graves' ophthalmopathy: results of a European questionnaire study.
Krassas GE; Segni M; Wiersinga WM
Eur J Endocrinol; 2005 Oct; 153(4):515-21. PubMed ID: 16189172
[TBL] [Abstract][Full Text] [Related]
15. Graves' disease in children.
Léger J; Oliver I; Rodrigue D; Lambert AS; Coutant R
Ann Endocrinol (Paris); 2018 Dec; 79(6):647-655. PubMed ID: 30180972
[TBL] [Abstract][Full Text] [Related]
16. The effect of propylthiouracil on subsequent radioactive iodine therapy in Graves' disease.
Hancock LD; Tuttle RM; LeMar H; Bauman J; Patience T
Clin Endocrinol (Oxf); 1997 Oct; 47(4):425-30. PubMed ID: 9404440
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcome of thyrotoxicosis in childhood and adolescence in the west of Scotland: the case for long-term antithyroid treatment and the importance of initial counselling.
Kourime M; McGowan S; Al Towati M; Ahmed SF; Stewart G; Williamson S; Hunter I; Donaldson MDC
Arch Dis Child; 2018 Jul; 103(7):637-642. PubMed ID: 29269558
[TBL] [Abstract][Full Text] [Related]
18. Assessing quality of life in Australian patients with Graves' ophthalmopathy.
Park JJ; Sullivan TJ; Mortimer RH; Wagenaar M; Perry-Keene DA
Br J Ophthalmol; 2004 Jan; 88(1):75-8. PubMed ID: 14693779
[TBL] [Abstract][Full Text] [Related]
19. Graves' disease: moving forwards.
Lane LC; Wood CL; Cheetham T
Arch Dis Child; 2023 Apr; 108(4):276-281. PubMed ID: 35831126
[TBL] [Abstract][Full Text] [Related]
20. [Evolution of diagnostic and therapeutic criteria in Graves' disease in Spain. Comparison of the results of 2 surveys in 1987 and 1995].
Escobar Jiménez F; Luna López V; Fernández Soto ML; Quezada Charneco M; Glinoer D
Med Clin (Barc); 1998 Sep; 111(6):205-10. PubMed ID: 9789225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
